Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM0UWNY)

Drug Name
Benzamide derivative 2 Drug Info
Synonyms PMID28051882-Compound-VI
Cross-matching ID
TTD Drug ID
DM0UWNY

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Sigma intracellular receptor 2 (TMEM97)
Drug Name Drug ID Indication ICD 11 Highest Status REF
MIN-101 DMCJY35 Schizophrenia 6A20 Phase 3 [2]
CT1812 DMBRKZ7 Alzheimer disease 8A20 Phase 2 [3]
Isoindoline derivative 5 DMIUTQW N. A. N. A. Patented [4]
Isoindoline derivative 3 DM2MYL9 N. A. N. A. Patented [4]
Isoindoline derivative 4 DMP1NKI N. A. N. A. Patented [4]
Isoindoline derivative 2 DMTE0S3 N. A. N. A. Patented [4]
Isoindoline derivative 1 DMD19QC N. A. N. A. Patented [4]
Benzamide derivative 9 DMVFSJZ N. A. N. A. Patented [4]
Benzamide derivative 10 DM9PKU2 N. A. N. A. Patented [4]
PMID30185082-Compound-57 DMNDF1Z N. A. N. A. Patented [4]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sigma intracellular receptor 2 (TMEM97) TT9NXW4 SGMR2_HUMAN Ligand [1]

References

1 Are sigma modulators an effective opportunity for cancer treatment A patent overview (1996-2016).Expert Opin Ther Pat. 2017 May;27(5):565-578.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 The sigma-2 (-2) receptor: a review of recent patent applications: 2013-2018.Expert Opin Ther Pat. 2018 Sep;28(9):655-663.